Europe Infectious Disease Diagnostics Market Forecast to 2028

Europe Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and Point of Care Testing), Disease Indication (HIV, Hepatitis, Healthcare-Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others), and End User (Hospitals and Clinics, Pathology/Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others)

Report Code : BMIRE00025318 | Region : Europe | Industry : Biotechnology | Published Date : 12/Jul/2022

The Europe infectious disease diagnostics market is expected to grow from US$ 7,164.17 million in 2021 to US$ 11,159.47 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028.

Research and development (R&D) are tremendously significant in the business of pharmaceuticals & biopharmaceutical companies. R&D enables these companies to develop new products for various therapeutic applications with significant medical and commercial potential. Further, leading market players are investing in R&D to develop advanced technologies and gain more revenue share. Moreover, testing is one of the best tools to understand and manage COVID-19. In response to the rising cases of COVID-19 and limited laboratory capabilities and molecular testing reagents, a few diagnostic testing manufacturers are offering fast and easy-to-use devices to facilitate out-of-laboratory testing. The simple test kits are based on detecting proteins of COVID-19 from respiratory samples (sputum and swabs of the throat) or human antibodies produced due to infection in blood or serum. Rising focus on R&D and funding in infectious disease diagnostics are driving the infectious disease diagnostics market growth across the region.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe infectious disease diagnostics market at a notable CAGR during the forecast period.

Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Europe Infectious Disease Diagnostics Market Segmentation

The Europe infectious disease diagnostics market is analyzed based on product, technology, testing type, disease indication and end user, and country. Based on product, the Europe infectious disease diagnostics market, has been segmented into kits and reagents, instruments, and software and services. The kits and reagents segment dominated the market in 2020 and software and services segment is expected to be fastest growing during forecast period. Based on technology, the market is segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on testing type, the market is segmented into laboratory testing and point of care testing. The laboratory testing segment dominated the market in 2020 and point of care testing segment is expected to be fastest growing during forecast period. Based on disease indication, the market is segmented into HIV, Hepatitis, Healthcare Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others. The hepatitis segment dominated the market in 2020 and healthcare- associated infections (HAIs) segment is expected to be fastest growing during forecast period. Based on end user, the Europe infectious disease diagnostics market, has been segmented into hospitals and clinics, pathology/ diagnostic laboratories, research institutes, home care settings, and others. The pathology/ diagnostic laboratories segment dominated the market in 2020 and home care settings segment is expected to be fastest growing during forecast period. Based on country, the Europe infectious disease diagnostics market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.

Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare are among the leading companies operating in the Europe infectious disease diagnostics market.

Kits and Reagents Segment to Dominate Europe Infectious Disease Diagnostics Market During 2021–2028

According to a new market research study on “Europe Infectious Disease Diagnostics Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Technology, Testing Type, Disease Indication and End User ” is expected to reach US$ 11,159.47 million by 2028 from US$ 7,164.17 million in 2021. The market is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The report provides trends prevailing in the Europe infectious disease diagnostics market along with the drivers and restraints pertaining to the market growth. I ncreasing focus on R&D and funding in infectious disease diagnostics is the major factor driving the growth of the Europe infectious disease diagnostics market . However, inadequate reimbursement scenario may hamper the growth of the market hinders the growth of Europe infectious disease diagnostics market .

The Europe infectious disease diagnostics market is analyzed based on product, technology, testing type, disease indication and end user, and country. Based on product, the Europe infectious disease diagnostics market, has been segmented into kits and reagents, instruments, and software and services. The kits and reagents segment dominated the market in 2020 and software and services segment is expected to be fastest growing during forecast period. Based on technology, the market is segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on testing type, the market is segmented into laboratory testing and point of care testing. The laboratory testing segment dominated the market in 2020 and point of care testing segment is expected to be fastest growing during forecast period. Based on disease indication, the market is segmented into HIV, Hepatitis, Healthcare Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others. The hepatitis segment dominated the market in 2020 and healthcare- associated infections (HAIs) segment is expected to be fastest growing during forecast period. Based on end user, the Europe infectious disease diagnostics market, has been segmented into hospitals and clinics, pathology/ diagnostic laboratories, research institutes, home care settings, and others. The pathology/ diagnostic laboratories segment dominated the market in 2020 and home care settings segment is expected to be fastest growing during forecast period. Based on country, the Europe infectious disease diagnostics market is segmented into the UK, Germany, France, Italy, Spain, and Rest of Europe.

Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare among the leading companies in the Europe infectious disease diagnostics market . The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, CerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX System has been CE marked to the IVD Directive (98/79/CE). The molecular test for detection of COVID-19 is available to clinical laboratories in countries recognizing the CE mark.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Infectious Disease Diagnostics Market – By Product

1.3.2 Europe Infectious Disease Diagnostics Market – By Technology

1.3.3 Europe Infectious Disease Diagnostics Market – By Testing Type

1.3.4 Europe Infectious Disease Diagnostics Market – By Disease Indication

1.3.5 Europe Infectious Disease Diagnostics Market – By End User

1.3.6 Europe Infectious Disease Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Infectious Disease Diagnostics Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Infectious Disease Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Infectious Diseases

5.1.2 Growing Focus on R&D and Funding in Infectious Disease Diagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Growing Opportunities in Developing Nations

5.4 Future Trend

5.4.1 Upsurge in the Number of Product Approvals and Launches

5.5 Impact Analysis

6. Infectious Disease Diagnostics Market– Europe Analysis

6.1 Europe Infectious Disease Diagnostics Market Revenue Forecast and Analysis

7. Europe Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 Europe by Product: Market Revenue and Forecast Analysis (US$ Million)

7.3 Kits and Reagents

7.3.1 Overview

7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology

8.1 Europe Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

8.2 Immunodiagnostics

8.2.1 Overview

8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Polymerase Chain Reaction (PCR)

8.3.1 Overview

8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Next Generation Sequencing

8.4.1 Overview

8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Clinical Microbiology

8.5.1 Overview

8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type

9.1 Europe Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

9.2 Laboratory Testing

9.2.1 Overview

9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Point of Care Testing

9.3.1 Overview

9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication

10.1 Overview

10.2 Europe Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

10.3 HIV

10.3.1 Overview

10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4 Hepatitis

10.4.1 Overview

10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

10.5 Healthcare Associated Infections (HAIs)

10.5.1 Overview

10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

10.6 Human Papillomavirus (HPV)

10.6.1 Overview

10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

10.7 Tuberculosis (TB)

10.7.1 Overview

10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

10.8 Influenza

10.8.1 Overview

10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)

10.9 Others

10.9.1 Overview

10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. Europe Infectious Disease Diagnostics Market Analysis – by End User

11.1 Overview

11.2 Europe Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

11.3 Hospitals and Clinics

11.3.1 Overview

11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Pathology or Diagnostic Laboratories

11.4.1 Overview

11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Research Institutes

11.5.1 Overview

11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.6 Home Care Settings

11.6.1 Overview

11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.7 Others

11.7.1 Overview

11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Country Analysis

12.1 Europe: Infectious Disease Diagnostics Market

12.1.1 Overview

12.1.2 Europe: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.1.2.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.2 Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.3 Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.4 Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.5 Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.6 Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.1 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.2 France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.3 France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.4 France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.5 France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.6 France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.1 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.2 UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.3 UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.4 UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.5 UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.6 UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.1 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.2 Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.3 Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.4 Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.5 Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.6 Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.1 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.2 Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.3 Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.4 Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.5 Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.6 Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.1 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.2 Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 Danaher

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Abbott

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 BD

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Trinity Biotech

14.4.1 1.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 F. HOFFMANN-LA ROCHE LTD.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Cardinal Health Inc.

14.6.1 1.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 bioMerieux SA

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 BIO-RAD LABORATORIES INC.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 AccuBioTech Co., Ltd.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 ACON Laboratories, Inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

LIST OF TABLES.

Table 1.             Europe Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Table 2.             Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 9.             France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 11.          France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12.          UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 13.          UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 14.          UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 15.          UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 16.          UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 19.          Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 24.          Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 29.          Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Organic Developments Done By Companies

Table 33.          Inorganic Developments Done By Companies

Table 34.          Glossary of Terms

LIST OF FIGURES.

Figure 1.           Europe Infectious Disease Diagnostics Market Segmentation

Figure 2.           Europe Infectious Disease Diagnostics Market, By Country

Figure 3.           Europe Infectious Disease Diagnostics Market Overview

Figure 4.           Europe Infectious Disease Diagnostics Market, by Product

Figure 5.           Europe Infectious Disease Diagnostics Market, by Country

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Europe Infectious Disease Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Infectious Disease Diagnostics Market– Revenue Forecast and Analysis

Figure 10.        Europe by Product: Market Analysis and Forecast 2021 and 2028 (%)

Figure 11.        Europe Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Instruments Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Software and Services Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

Figure 15.        Europe Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

Figure 21.        Europe Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

Figure 24.        Europe HIV Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Europe Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Europe Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Europe Influenza Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Europe Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Europe Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

Figure 32.        Europe Hospitals: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Europe Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Europe Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Europe Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Europe Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Europe: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 38.        Europe: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 39.        Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Europe Infectious Disease Diagnostics Market

● Abbott

● AccuBioTech Co., Ltd.

● ACON Laboratories, Inc.

● BD

● bioMerieux SA

● BIO-RAD LABORATORIES INC.

● Cardinal Health Inc

● Danaher

● F. HOFFMANN-LA ROCHE LTD.

● Trinity Biotech

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe infectious disease diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Europe infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the infectious disease diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP